Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments ; volume:24 ; number:1 ; day:11 ; month:7 ; year:2024 ; pages:1-18 ; date:12.2024
Cancer cell international ; 24, Heft 1 (11.7.2024), 1-18, 12.2024
- Creator
-
Yan, Zhuo
Zhang, Zhengbo
Chen, Yanan
Xu, Jianghua
Wang, Jilong
Wang, Zhangquan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-024-03424-z
- URN
-
urn:nbn:de:101:1-2409282101230.295682527286
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yan, Zhuo
- Zhang, Zhengbo
- Chen, Yanan
- Xu, Jianghua
- Wang, Jilong
- Wang, Zhangquan
- SpringerLink (Online service)
Other Objects (12)
Viral Oncolytic Therapy
Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines
Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
Advances in antitumour therapy with oncolytic herpes simplex virus combinations
Modeling oncolytic virus therapy with distributed delay and nonlocal diffusion
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy
Oncolytic vaccinia therapy of squamous cell carcinoma
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Viral Oncolytic Therapy
Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines
Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
Advances in antitumour therapy with oncolytic herpes simplex virus combinations
Modeling oncolytic virus therapy with distributed delay and nonlocal diffusion
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy
Oncolytic vaccinia therapy of squamous cell carcinoma
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Viral Oncolytic Therapy
Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines
Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
Advances in antitumour therapy with oncolytic herpes simplex virus combinations
Modeling oncolytic virus therapy with distributed delay and nonlocal diffusion
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy
Oncolytic vaccinia therapy of squamous cell carcinoma